News Updates
More Articles
- Advancing the Implementation of ICH E17: Collaborative Efforts Driving Simultaneous Global Drug Development in China
- How to Build Partnerships for Sustainable Healthcare
- eCTD v4.0: A Look at 2025 and Beyond
- Accelerated Approval as the New “Norm” in Gene Therapy for Rare Diseases
- Data Distortions: When Statistics Can Lead Us Astray in Drug Safety
Advancing the Implementation of ICH E17: Collaborative Efforts Driving Simultaneous Global Drug Development in China
Advancing ICH E17: Driving Simultaneous Global Drug Development in China
This article provides examples from a groundbreaking collaboration to implement ICH E17 in multiregional clinical trials in China.
×
